spss v.15.0 software (SSPS Inc)
90
Structured Review
SSPS Inc
spss v.15.0 software
Spss V.15.0 Software, supplied by SSPS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spss+v%2E15%2E0+software/spss+v+15+0+software/pm24285860-33-35-37
Average 90 stars, based on 1 article reviews
Spss V.15.0 Software, supplied by SSPS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spss+v%2E15%2E0+software/spss+v+15+0+software/pm24285860-33-35-37
Average 90 stars, based on 1 article reviews
spss v.15.0 software - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Methylated DNA Immunoprecipitation:Article Title: Correlation between FMR1 expression and clinical phenotype in discordant dichorionic-diamniotic monozygotic twin sisters with the fragile X mutation. Article Snippet: To cite: Huang W, Luo S, Ou J, et al. J Med Genet Published Online First: [please include Day Month Year] doi:10.1136/ jmedgenet-2013-101978 ABSTRACT Background The clinical phenotypes of females with fragile X full mutations vary drastically.. Comparisons of discordant monozygotic twins provide opportunities to ascertain crucial factors that influence disease phenotype penetrance.. Objective To identify crucial factors influencing the phenotypic expression of fragile X syndrome (FXS). Software:Article Title: Correlation between FMR1 expression and clinical phenotype in discordant dichorionic-diamniotic monozygotic twin sisters with the fragile X mutation. Article Snippet: To cite: Huang W, Luo S, Ou J, et al. J Med Genet Published Online First: [please include Day Month Year] doi:10.1136/ jmedgenet-2013-101978 ABSTRACT Background The clinical phenotypes of females with fragile X full mutations vary drastically.. Comparisons of discordant monozygotic twins provide opportunities to ascertain crucial factors that influence disease phenotype penetrance.. Objective To identify crucial factors influencing the phenotypic expression of fragile X syndrome (FXS). |